Charles Schwab Investment Management Inc Chimerix Inc Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$1.1 - $1.54 $211,257 - $295,760	-192,052 Reduced 83.58%	37,732 $45,000
Q4 2022 Feb 13, 2023	BUY	$1.67 - $2.35 $12,393 - $17,439	7,421 Added 3.34%	229,784 $427,000
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $505,263 - $770,456	-279,151 Reduced 55.66%	222,363 $430,000
Q2 2022 Aug 15, 2022	SELL	$1.34 - $5.34 $35,593 - $141,841	-26,562 Reduced 5.03%	501,514 $1.04 Million
Q1 2022 May 13, 2022	SELL	$4.58 - $6.8 $130,548 - $193,827	-28,504 Reduced 5.12%	528,076 $2.42 Million
Q4 2021 Feb 11, 2022	BUY	$5.23 - $7.18 $62,692 - $86,066	11,987 Added 2.2%	556,580 $3.58 Million
Q3 2021 Nov 16, 2021	SELL	$5.94 - $8.75 $12,034 - $17,727	-2,026 Reduced 0.37%	544,593 $3.37 Million
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $277,547 - $360,369	36,810 Added 7.22%	546,619 $4.37 Million
Q1 2021 May 17, 2021	BUY	$4.76 - $11.25 $928,319 - $2.19 Million	195,025 Added 61.96%	509,809 $4.92 Million
Q4 2020 Feb 16, 2021	BUY	$2.43 - $5.42 $17,197 - $38,357	7,077 Added 2.3%	314,784 $1.52 Million
Q3 2020 Nov 13, 2020	SELL	$2.3 - $3.72 $27,319 - $44,186	-11,878 Reduced 3.72%	307,707 $767,000
Q2 2020 Aug 14, 2020	BUY	$1.33 - $3.63 $6,269 - $17,111	4,714 Added 1.5%	319,585 $991,000
Q1 2020 May 15, 2020	BUY	$1.27 - $2.33 $5,847 - $10,727	4,604 Added 1.48%	314,871 $454,000
Q4 2019 Feb 07, 2020	BUY	$1.3 - $2.72 $62,059 - $129,847	47,738 Added 18.18%	310,267 $630,000
Q3 2019 Nov 08, 2019	SELL	$1.93 - $4.21 $25,427 - $55,466	-13,175 Reduced 4.78%	262,529 $617,000
Q2 2019 Aug 09, 2019	BUY	$2.05 - $4.32 $58,193 - $122,631	28,387 Added 11.48%	275,704 $1.19 Million
Q1 2019 May 14, 2019	SELL	$1.79 - $3.12 $168 - $293	-94 Reduced 0.04%	247,317 $520,000
Q4 2018 Feb 14, 2019	SELL	$2.24 - $3.9 $5,474 - $9,531	-2,444 Reduced 0.98%	247,411 $636,000
Q3 2018 Nov 13, 2018	BUY	$3.58 - $4.9 $95,464 - $130,663	26,666 Added 11.95%	249,855 $972,000
Q2 2018 Aug 08, 2018	BUY	$4.43 - $5.14 $156,006 - $181,010	35,216 Added 18.73%	223,189 $1.06 Million
Q1 2018 May 07, 2018	SELL	$4.65 - $5.9 $110,121 - $139,723	-23,682 Reduced 11.19%	187,973 $978,000
Q4 2017 Jan 17, 2018	BUY	$4.32 - $5.52 $46,500 - $59,417	10,764 Added 5.36%	211,655 $980,000
Q3 2017 Nov 13, 2017	BUY	$4.35 - $5.25 $873,875 - $1.05 Million	200,891	200,891 $1.06 Million

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account